Glial Cells Could Be Key to Reducing Neuroinflammation
QPS Neuro
Neuroinflammation, or inflammation in the central nervous system, has been linked to a number of neurodegenerative disorders including Alzheimer’s disease and multiple sclerosis. Experts know that pro-inflammatory molecules can have a devastating effect on the brain and spinal cord, but the exact mechanism of some of these molecules, as well as immune cells like glial …
Impact of Tau Protein on Parkinson’s Disease Progression
QPS Neuro
As many as 10 million people worldwide are estimated to be living with Parkinson’s disease, a progressive neurological disorder that affects movement control. As the global population ages, Parkinson’s disease remains a significant public health concern, making ongoing medical research an urgent priority. Now, a new study published in the journal Brain may shed light …
Could Pesticides Lead to Parkinson’s Disease?
QPS Neuro
Neurological disorders are now the leading source of disability around the world. Within that category, Parkinson’s Disease (PD) is the fastest-growing neurological disorder, impacting more than 8.5 million people globally. Researchers have identified a number of environmental factors that contribute to the disease’s unprecedented rise — and the evidence is increasingly pointing to pesticides. Unfortunately, …
Is mRNA the Key to Treating Parkinson’s Disease?
QPS Neuro
Parkinson’s Disease (PD) impacts as many as 500,000 Americans, though some estimates put that number as high as 1 million. There is currently no cure for PD, which means that healthcare providers are constantly on the lookout for effective therapeutic treatments to improve patients’ quality of life. Now, researchers at the Scripps Research Institute have developed a new …
Could Malfunctioning Mitochondria Predict Alzheimer’s Disease?
QPS Neuro
Alzheimer’s Disease, or AD, is an incurable neurodegenerative condition that generally appears in individuals over the age of 65. However, scientists now believe that certain predictors can appear in a patient’s brain decades before symptoms appear — specifically, malfunctioning mitochondria. With that in mind, researchers at the European Synchrotron Radiation Facility (ESRF) recently posed an …